Research Analysts Set Expectations for BCAX FY2025 Earnings
Bicara Therapeutics Inc. (NASDAQ:BCAX - Free Report) - Investment analysts at Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of Bicara Therapeutics in a research note issued on Monday, March 31st. Cantor Fitzgerald analyst E. Schmidt now forecasts that the company will earn ($1.8.
Publicado el: 2025-04-03 10:18:06
Autor: lulegacy, Fuente: lulegacy
Compartir: 
